Profile
Christopher Sweeney is Medical Director of Semafore Pharmaceuticals, Inc. and Clinical Director of the Developmental Therapeutics Program for the Division of Hematology and Oncology of the IU Medical School Cancer Center.
He was an Internal Medicine Resident of the Gundersen Lutheran Medical Center from 1994 to 1997 and a Fellow in Hematology and Oncology of the Indiana University Medical Center from 1997 to 2000.
He received an MD from the University of Adelaide in 1992.
Former positions of Christopher Sweeney
Companies | Position | End |
---|---|---|
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Training of Christopher Sweeney
University of Adelaide | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Semafore Pharmaceuticals, Inc.
Semafore Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Semafore Pharmaceuticals, Inc. develops and discovers drugs for multiple disorders including cancer. The company was founded by Christopher J. Garlich and Ronald Michal in 2000 and is headquartered in Indianapolis, IN. | Retail Trade |
- Stock Market
- Insiders
- Christopher Sweeney